| EUR | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 137.45B | 139.95B | 119.67B | 79.86B |
| YoY Growth | -1.8% | +16.9% | +49.8% | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| R&D | — | — | — | — |
| SG&A | 5.34B | 5.16B | 4.75B | 11.17B |
| EBIT | — | — | — | — |
| EBIT Margin | — | — | — | — |
| D&A | 2.18B | 2.15B | 2.27B | 2.18B |
| EBITDA | — | — | — | — |
| EBITDA Margin | — | — | — | — |
| Net Income | 10.78B | 9.93B | 8.54B | 6.42B |
| Net Margin | 7.8% | 7.1% | 7.1% | 8.0% |
| EPS (diluted) | €27.67 | €25.18 | €21.18 | €15.48 |
| Shares (dil., M) | 383 | 389 | 396 | 406 |
| Gross Margin | — |
|---|---|
| EBITDA Margin | — |
| EBIT Margin | — |
| Net Margin | 7.8% |
| FCF Margin | 22.5% |
| ROIC | — |
|---|---|
| ROCE | — |
| ROE | 17.2% |
| ROA | 1.1% |
| Asset Turnover | 0.13× |
| FCF / Net Income | 287.2% |
|---|---|
| SBC / Net Income | — |
| SBC / Revenue | — |
| Capex / D&A | 1.04× |
| Metric | 3yr |
|---|---|
| Revenue | 19.8% |
| EPS | 21.4% |
| FCF | 23.7% |
| Dividend | — |
| Float | 100.0% |
|---|---|
| Shares Out. | 380.2M |
| Insiders % | 0.3% |
| Institutions % | 75.2% |
| Institutions (of float) | 75.5% |
| Institution holders | 561 |
| Insider net buy 6M | +0.1% |
| Cash & ST Invest. | €600.1B |
|---|---|
| Total Debt | €35.3B |
| Net Cash / (Debt) | -€5.4B |
| Total Assets | €1.02T |
| Total Equity | €62.7B |
| Goodwill & Intang. | €18.6B |
| Tangible Book Value | €44.1B |
| NCAV (Graham) | — |
| Tangible Book/sh | €115.98 |
| NCAV/sh | — |
| D/E Ratio | 0.56× |
|---|---|
| Net Debt / EBITDA | — |
| Interest Coverage | — |
| Current Ratio | — |
| Quick Ratio | — |
| Capex | €2.3B |
|---|---|
| Capex / Revenue | 1.6% |
| SBC | — |
| Dividends Paid | €6.4B |
| Buybacks | €3.1B |
| Annual DPS | €17.10 |
|---|---|
| Yield (fwd) | 4.63% |
| Payout Ratio | 55.7% |
| Ex-div Date | 2026-05-08 |
| P/E vs 4Y | 13.6×vs 4.6× median |
|---|---|
| Div yield vs 10Y | 440.0%vs 14.9% median |
| Gross Margin | — |
|---|---|
| EBITDA Margin | — |
| EBIT Margin | — |
| Net Margin | 7.8% |
| FCF Margin | 22.5% |
| ROIC | — |
|---|---|
| ROCE | — |
| ROE | 17.2% |
| ROA | 1.1% |
| Asset Turnover | 0.13× |
| FCF / Net Income | 287.2% |
|---|---|
| SBC / Net Income | — |
| SBC / Revenue | — |
| Capex / D&A | 1.04× |
| Metric | 3yr |
|---|---|
| Revenue | 19.8% |
| EPS | 21.4% |
| FCF | 23.7% |
| Dividend | — |
| Float | 100.0% |
|---|---|
| Shares Out. | 380.2M |
| Insiders % | 0.3% |
| Institutions % | 75.2% |
| Institutions (of float) | 75.5% |
| Institution holders | 561 |
| Insider net buy 6M | +0.1% |
| EUR | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 137.45B | 139.95B | 119.67B | 79.86B |
| YoY Growth | -1.8% | +16.9% | +49.8% | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| R&D | — | — | — | — |
| SG&A | 5.34B | 5.16B | 4.75B | 11.17B |
| EBIT | — | — | — | — |
| EBIT Margin | — | — | — | — |
| D&A | 2.18B | 2.15B | 2.27B | 2.18B |
| EBITDA | — | — | — | — |
| EBITDA Margin | — | — | — | — |
| Net Income | 10.78B | 9.93B | 8.54B | 6.42B |
| Net Margin | 7.8% | 7.1% | 7.1% | 8.0% |
| EPS (diluted) | €27.67 | €25.18 | €21.18 | €15.48 |
| Shares (dil., M) | 383 | 389 | 396 | 406 |
| Cash & ST Invest. | €600.1B |
|---|---|
| Total Debt | €35.3B |
| Net Cash / (Debt) | -€5.4B |
| Total Assets | €1.02T |
| Total Equity | €62.7B |
| Goodwill & Intang. | €18.6B |
| Tangible Book Value | €44.1B |
| NCAV (Graham) | — |
| Tangible Book/sh | €115.98 |
| NCAV/sh | — |
| D/E Ratio | 0.56× |
|---|---|
| Net Debt / EBITDA | — |
| Interest Coverage | — |
| Current Ratio | — |
| Quick Ratio | — |
| Capex | €2.3B |
|---|---|
| Capex / Revenue | 1.6% |
| SBC | — |
| Dividends Paid | €6.4B |
| Buybacks | €3.1B |
| Annual DPS | €17.10 |
|---|---|
| Yield (fwd) | 4.63% |
| Payout Ratio | 55.7% |
| Ex-div Date | 2026-05-08 |
| P/E vs 4Y | 13.6×vs 4.6× median |
|---|---|
| Div yield vs 10Y | 440.0%vs 14.9% median |